An exploratory survey about using ChatGPT in education, healthcare, and research.
Journal
medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986
Informations de publication
Date de publication:
03 Apr 2023
03 Apr 2023
Historique:
medline:
18
4
2023
entrez:
17
4
2023
pubmed:
18
4
2023
Statut:
epublish
Résumé
Objective ChatGPT is the first large language model (LLM) to reach a large, mainstream audience. Its rapid adoption and exploration by the population at large has sparked a wide range of discussions regarding its acceptable and optimal integration in different areas. In a hybrid (virtual and in-person) panel discussion event, we examined various perspectives regarding the use of ChatGPT in education, research, and healthcare. Materials and Methods We surveyed in-person and online attendees using an audience interaction platform (Slido). We quantitatively analyzed received responses on questions about the use of ChatGPT in various contexts. We compared pairwise categorical groups with Fisher's Exact. Furthermore, we used qualitative methods to analyze and code discussions. Results We received 420 responses from an estimated 844 participants (response rate 49.7%). Only 40% of the audience had tried ChatGPT. More trainees had tried ChatGPT compared with faculty. Those who had used ChatGPT were more interested in using it in a wider range of contexts going forwards. Of the three discussed contexts, the greatest uncertainty was shown about using ChatGPT in education. Pros and cons were raised during discussion for the use of this technology in education, research, and healthcare. Discussion There was a range of perspectives around the uses of ChatGPT in education, research, and healthcare, with still much uncertainty around its acceptability and optimal uses. There were different perspectives from respondents of different roles (trainee vs faculty vs staff). More discussion is needed to explore perceptions around the use of LLMs such as ChatGPT in vital sectors such as education, healthcare and research. Given involved risks and unforeseen challenges, taking a thoughtful and measured approach in adoption would reduce the likelihood of harm.
Identifiants
pubmed: 37066228
doi: 10.1101/2023.03.31.23287979
pmc: PMC10104227
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : NHLBI NIH HHS
ID : F32 HL162377
Pays : United States
Organisme : NHLBI NIH HHS
ID : K23 HL155970
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001422
Pays : United States
Commentaires et corrections
Type : UpdateIn
Références
Res Integr Peer Rev. 2023 May 18;8(1):4
pubmed: 37198671
Natl Med J India. 2023 Jan-Feb;36(1):1-4
pubmed: 37615142
Eur Radiol. 2023 Oct 5;:
pubmed: 37794249
PLOS Digit Health. 2023 Feb 9;2(2):e0000198
pubmed: 36812645
JAMA. 2023 Feb 28;329(8):637-639
pubmed: 36719674
Account Res. 2023 Jan 25;:1-9
pubmed: 36697395
JMIR Med Educ. 2023 Jul 10;9:e46939
pubmed: 37428540
JAMIA Open. 2018 May 23;1(1):26-31
pubmed: 31984317
JAMA Intern Med. 2021 Aug 1;181(8):1065-1070
pubmed: 34152373